The Increasing Prevalence of Western Diseases in Africa

In the past decade, Africa has witnessed an increase in the occurrence of Western Diseases resulting in an escalating demand for medicines which has contributed significantly to the growth of the pharmaceutical industry in the region.
 
March 3, 2011 - PRLog -- Cape Town - 3 March 2011 – The Healthcare group at Frost & Sullivan (http://www.healthcare.frost.com/) is pleased to announce that it will be hosting its first quarter analyst briefing webinar on The Increasing Prevalence of Western Diseases in Africa on Wednesday 9th March 2011 at 2pm GMT / 4pm CAT.

In the past decade, Africa has witnessed an increase in the occurrence of Western Diseases resulting in an escalating demand for medicines which has contributed significantly to the growth of the pharmaceutical industry in the region.  Characterised by an extremely poor population and an emerging middle class, Africa offers lucrative opportunities for both generic and branded pharmaceutical companies. It is important that any company operating in this market position itself optimally in order to become a leader in the market.  

In its upcoming analyst briefing webinar taking place on 9th March 2011, Frost & Sullivan aims to highlight the key challenges, drivers and restraints in the African Pharmaceutical Industry as well as projected revenue forecasts for East, West and Southern Africa. Tinotenda Sachikonye, Frost & Sullivan’s Healthcare Research Analyst explains, “Pharmaceutical regulatory bodies in the region are becoming more efficient and the challenges associated with illegal and substandard products on the market are being addressed. This has resulted in further growth in the legitimate market, with compound annual growth rates of up to 16 per cent in the cardiovascular and diabetes therapeutic segments forecast in the region for the period 2010-2016.”

Frost & Sullivan’s discussion on the key trends in the pharmaceutical industry in Africa and projections for this industry will benefit current market participants, new entrants, as well as investors.

To participate in this complimentary analyst briefing webinar, please email Christie Cronje at Christie.cronje@frost.com, Corporate Communications, with the following information: your full name, company name, title, telephone number, e-mail, address, city and country. Upon receipt of the above information, a registration link will be e-mailed to you. You may also register to receive a recorded version of the briefing at anytime by submitting the aforementioned contact details.
 
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

CONTACT:  
Christie Cronje
Corporate Communications Manager: Africa
P: +27 21 680 3566
E: christie.cronje@frost.com
http://www.frost.com
Twitter: twitter.com/frost_sullivan
www.facebook.com/FrostandSullivan

# # #

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's research and consulting services empower clients to generate, evaluate, and implement effective growth strategies.
End
Source: » Follow
Email:***@frost.com Email Verified
Tags:Disease, Africa, Webinar, Pharmeutical Industry, Medecine, Healthcare
Industry:Medical
Location:Cape Town - Western Cape - South Africa
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Frost & Sullivan PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share